Navigation Links
New Vision Test Helps Detect Optic Nerve Diseases Including Glaucoma
Date:3/28/2011

PINE BROOK, N.J., March 28, 2011 /PRNewswire/ -- Diopsys, Inc. has launched the new Diopsys® NOVA-DN VEP Vision Testing System to help optometrists and ophthalmologists detect optic nerve disease, including glaucoma and other neuro-visual disorders.

Glaucoma is the second leading cause of blindness in the world, reports the World Health Organization. According to Prevent Blindness America, glaucoma is often called the "sneak thief of sight" because half of all patients who have it do not know it.  Many optic nerve disorders, such as glaucoma and ischemic optic neuropathy, are asymptomatic since central vision may not be affected until later stages of the disease. Also, diagnosis and management of optic nerve disorders are often based on structural or visual field tests which are limited in their ability to detect disease early.  

The Diopsys® NOVA-DN allows clinicians to objectively assess optic nerve disease earlier than traditional vision tests because it uses Visual Evoked Potential (VEP) technology and proprietary software to evaluate the entire vision system from the eye to the visual cortex. "VEP is an objective, functional test that can help discriminate between healthy and glaucomatous eyes," says Alberto Gonzalez Garcia, M.D., neuro-ophthalmologist and Research Director at Diopsys, Inc. Optometrists and ophthalmologists may use VEP in addition to traditional testing methods to enhance diagnosis and treatment.

The Diopsys® NOVA-DN records the electrical response of a patient's entire vision system and provides easy-to-read reports that give the doctor a simple way to evaluate optic nerve function.  Physicians are able to compare tests over time to track disease progression.

Dr. Fran Bucciero of Family Vision Care in Springfield, NJ, one of the first eye care professionals to have the device in his office says, "I've been using the Diopsys® NOVA-DN in my practice to help me diagnose glaucoma patients, and to track their disease progression. Because of the straightforward reports, I am able to show my patients how well their treatment is working which helps enormously with treatment compliance."  

Diopsys, Inc. (http://www.diopsys.com) is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care.  The company specializes in the development and marketing of patient-friendly, non-invasive diagnostic vision testing equipment.  Diopsys has developed and markets the patented Enfant® Pediatric Vision Testing System, a device used by pediatricians to test for visual deficits, including amblyopia, in children as young as six months of age. Diopsys also developed and markets the Diopsys® NOVA-DT (Diagnostic & Tracking), Diopsys® NOVA-TR (Transient Response) and Diopsys® NOVA-DN (Diseases of the Optic Nerve)  Vision Testing Systems utilized by ophthalmologists and optometrists for the detection, diagnosis and treatment of vision disorders.


'/>"/>
SOURCE Diopsys, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. In a Phase 2 Study PF-04523655 (RTP801I-14) Showed Improved Vision Over Standard of Care in Patients with Diabetic Macular Edema at 12 Months
2. CooperVision Introduces New Corporate Brand Identity
3. New Ad Campaign: Secret Provision Raises Taxes on Prescription Drug Benefits, Creates Conflict of Interest
4. Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCares Global Consumer Care Division
5. TLC Vision Announces TLC Laser Eye Center San Diego
6. Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
7. New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92%
8. Sevocity, a Division of Conceptual MindWorks, Incs Sevocity Receives ONC-ATCB 2011/2012 Certification
9. HealthWarehouse.com Acquires Online Division of Hocks Pharmacy
10. Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
11. Elka Nir Joins VisionCare Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
(Date:4/18/2017)... Viverae ® , a leader in workplace ... IBM ® Watson Campaign Automation, implementing behavioral messaging ... a personalized experience. Through digital engagement, the platform prompts ... real time. The enhanced experience drives engagement by focusing ... they are in their journey to health. ...
Breaking Medicine Technology:
(Date:4/29/2017)... ... April 29, 2017 , ... ... and recognize the positive impact veterinarians have on animal health and welfare as ... Organization for Animal Health (OIE) choose a theme each year and this year ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... National Campaign) announces its support for the Access to Contraception for Women Servicemembers ... (D-NH) and Rep. Jackie Speier (D-CA), will help to ensure that all members ...
(Date:4/28/2017)... ... April 28, 2017 , ... It's not always common knowledge whether or not ... are unclear as to whether or not they are contagious, and most people don't ... illnesses. So, FindaTopDoc took a look into the matter. , They discovered that ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... , ... Getting enough sleep affects much more than energy – it also has mental and ... can compromise motor reaction time, which can increase the risk of having a car accident. ... tips from the NSF to help you sleep better and feel better:, ...
Breaking Medicine News(10 mins):